切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2023, Vol. 19 ›› Issue (05) : 611 -615. doi: 10.3877/cma.j.issn.1673-5250.2023.05.016

综述

妊娠合并子宫肌瘤的孕期变化及其与不良妊娠结局的关系
周梦玲, 薛志伟, 周淑()   
  1. 四川大学华西第二医院产科、出生缺陷与相关妇儿疾病教育部重点实验室,成都 610041;成都市双流区妇幼保健院产科,成都 610299
    四川大学华西第二医院产科、出生缺陷与相关妇儿疾病教育部重点实验室,成都 610041
  • 收稿日期:2023-06-01 修回日期:2023-09-10 出版日期:2023-10-01
  • 通信作者: 周淑

Changes in size of uterine myoma during pregnancy and its association with adverse pregnancy outcomes

Mengling Zhou, Zhiwei Xue, Shu Zhou()   

  1. Department of Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China; Department of Obstetrics, Chengdu Shuangliu District Maternity and Child Health Care Hospital, Chengdu 610299, Sichuan Province, China
    Department of Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
  • Received:2023-06-01 Revised:2023-09-10 Published:2023-10-01
  • Corresponding author: Shu Zhou
  • Supported by:
    National Key Research and Development Project(2018YFC1004603)
引用本文:

周梦玲, 薛志伟, 周淑. 妊娠合并子宫肌瘤的孕期变化及其与不良妊娠结局的关系[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 611-615.

Mengling Zhou, Zhiwei Xue, Shu Zhou. Changes in size of uterine myoma during pregnancy and its association with adverse pregnancy outcomes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 611-615.

子宫肌瘤(UM)是女性生殖道最常见良性肿瘤,好发于育龄期,病因迄今尚未阐明,其发生、发展可能与雌、孕激素等相关。虽然孕期胎盘产生雌、孕激素水平随着孕龄增加而增加,但是UM体积,并非随着雌、孕激素水平升高而相应增大。孕期母体产生的其他内分泌激素及羊膜腔张力、子宫收缩等因素,同样也影响着UM血供及生长方式。妊娠合并UM是一些不良妊娠结局的高危因素,如可能导致早产、胎盘早剥、产后出血等,同时也可增加剖宫产术分娩率。因此,本文拟结合国内外相关文献对妊娠合并UM在孕期的变化,及其与不良妊娠结局的关系进行综述如下,旨在提高临床医师对妊娠合并UM的认识,为临床正确管理妊娠合并UM提供思路。

Uterine myoma (UM) is the most common benign tumor of the female genital tract, which often occurs in their reproductive age, the cause has not been clarified so far, and its occurrence and development may be related to estrogen and progesterone. Although the levels of estrogen and progesterone produced in the placenta during pregnancy increases with the increase of gestational age, but the volume of UM does not increase with the increase of estrogen and progesterone levels. Other endocrine hormones produced by the body during pregnancy, and amniotic cavity tension, uterine contraction and other factors also affect the blood supply and growth mode of uterine myoma. Pregnancy complicated with UM is a high risk factor for some adverse pregnancy outcomes, such as premature delivery, placental abruption, postpartum hemorrhage etc., and also increases the rate of cesarean delivery. Therefore, this article combines relevant literature at domestic and abroad to analyze the changes of UM during pregnancy and their association with adverse pregnancy outcomes, to improve the clinical understanding of pregnancy with UM and to provide ideas for clinical correct management of pregnancy with UM.

[1]
Sobel M, Hobson S, Chan C. Uterine fibroids in pregnancy[J]. Can Med Assoc J, 2022, 194(22): e775. DOI: 10.1503/cmaj.211530.
[2]
Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids[J]. Int J Gynaecol Obstet, 2020, 149(1): 3-9. DOI: 10.1002/ijgo.13102.
[3]
Wang X, Wang G, Han R, et al. Uterine fibroids increase the risk of preterm birth and other adverse birth events: a systematic review and Meta-analysis[J]. Transl Pediatr, 2022, 11(6): 978-986. DOI: 10.21037/tp-22-215.
[4]
谢幸,孔北华,段涛,等. 妇产科学[M]. 9版. 北京:人民卫生出版社,2018: 303-306.
[5]
Reis FM, Bloise E, Ortiga-Carvalho TM. Hormones and pathogenesis of uterine fibroids[J]. Best Pract Res Clin Obstet Gynaecol, 2016, 34: 13-24. DOI: 10.1016/j.bpobgyn.2015.11.015.
[6]
Landman AJEMC, Don EE, Vissers G, et al. The risk of preterm birth in women with uterine fibroids: a systematic review and Meta-analysis[J]. PLoS One, 2022, 17(6): e0269478. DOI: 10.1371/journal.pone.0269478.
[7]
Pandit U, Singh M, Ranjan R. Assessment of maternal and fetal outcomes in pregnancy complicated by fibroid uterus[J]. Cureus, 2022, 14(2): e22052. DOI: 10.7759/cureus.22052.
[8]
Yang Q, Al-Hendy A. Update on the role and regulatory mechanism of extracellular matrix in the pathogenesis of uterine fibroids[J]. Int J Mol Sci, 2023, 24(6): 5778. DOI: 10.3390/ijms24065778.
[9]
Yang Q, Ciebiera M, Bariani MV, et al. Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment[J]. Endocr Rev, 2022, 43(4): 678-719. DOI: 10.1210/endrev/bnab039.
[10]
Mitro SD, Peddada S, Chen Z, et al. Natural history of fibroids in pregnancy: national Institute of Child Health and Human Development Fetal Growth Studies - Singletons cohort[J]. Fertil Steril, 2022, 118(4): 656-665. DOI: 10.1016/j.fertnstert.2022.06.028.
[11]
Chill HH, Karavani G, Rachmani T, et al. Growth pattern of uterine leiomyoma along pregnancy[J]. BMC Women′s Heath, 2019, 19(1): 1-5. DOI: 10.1186/s12905-019-0803-5.
[12]
Laughlin SK, Herring AH, Savitz DA, et al. Pregnancy-related fibroid reduction[J]. Fertil Steril, 2010, 94(6): 2421-2423. DOI: 10.1016/j.fertnstert.2010.03.035.
[13]
Mesi Edzie EK, Dzefi-Tettey K, Brakohiapa EK, et al. Assessment of the clinical presentations and ultrasonographic features of uterine fibroids in adult africans: a retrospective study[J]. Oman Med J, 2023, 38(1): e459. DOI: 10.5001/omj.2023.36.
[14]
Sarais V, Cermisoni GC, Schimberni M, et al. Human chorionic gonadotrophin as a possible mediator of leiomyoma growth during pregnancy: molecular mechanisms[J]. Int J Mol Sci, 2017, 18(9): 2014. DOI: 10.3390/ijms18092014.
[15]
Delli Carpini G, Verdecchia V, Papiccio M, et al. Comparison of uterine fibroids′ growth pattern during pregnancy according to fetal sex: an observational study[J]. Biol Sex Differ, 2019, 10(1): 53. DOI: 10.1186/s13293-019-0266-2.
[16]
Reis-de-Carvalho C, Lopes J, Henriques A, et al. Management of pregnancy in case of multiple and giant uterine fibroids[J]. BMJ Case Rep, 2020, 13(11): e235572. DOI: 10.1136/bcr-2020-235572.
[17]
薛智方,吴跃芹,王细先,等. 子宫肌瘤患者孕产时并发症、分娩结局及新生儿结局分析[J]. 医学综述2018, 24(22): 4573-4576. DOI: 10.3969/j.issn.1006-2084.2018.22.039.
[18]
Delli Carpini G, Morini S, Papiccio M, et al. The association between childbirth, breastfeeding, and uterine fibroids: an observational study[J]. Sci Rep, 2019, 9(1): 10117. DOI: 10.1038/s41598-019-46513-0.
[19]
Farland LV, Stern JE, Liu CL, et al. Pregnancy outcomes among women with endometriosis and fibroids: registry linkage study in Massachusetts[J]. Am J Obstet Gynecol, 2022, 226(6): 829.e1-829.e14. DOI: 10.1016/j.ajog.2021.12.268.
[20]
Kim HJ, Lee J, Lee HJ. Differential diagnosis of uterine leiomyoma torsion mimicking ovarian torsion in a second trimester of pregnancy: a case report[J]. Int J Women′s Heath, 2022, 14: 1777-1782. DOI: 10.2147/ijwh.s385321.
[21]
Freytag D, Günther V, Maass N, et al. Uterine fibroids and infertility[J]. Diagnostics (Basel), 2021, 11(8): 1455. DOI: 10.3390/diagnostics11081455.
[22]
欧阳彦兰,曾喜群,黄燕婷,等. 妊娠合并子宫肌瘤孕妇先兆流产发生的危险因素[J]. 中国医药科学2021, 11(22): 145-148. DOI: 10.3969/j.issn.2095-0616.2021.22.039.
[23]
Datir SG, Bhake A. Management of uterine fibroids and its complications during pregnancy: a review of literature[J]. Cureus, 2022, 14(11): e31080. DOI: 10.7759/cureus.31080.
[24]
Hartmann KE, Velez Edwards DR, Savitz DA, et al. Prospective cohort study of uterine fibroids and miscarriage risk[J]. Am J Epidemiol, 2017, 186(10): 1140-1148. DOI: 10.1093/aje/kwx062.
[25]
Sundermann AC, Velez Edwards DR, Bray MJ, et al. Leiomyomas in pregnancy and spontaneous abortion: a systematic review and Meta-analysis[J]. Obstet Gynecol, 2017, 130(5): 1065-1072. DOI: 10.1097/AOG.0000000000002313.
[26]
Girault A, Le Ray C, Chapron C, et al. Leiomyomatous uterus and preterm birth: an exposed/unexposed monocentric cohort study[J]. Am J Obstet Gynecol, 2018, 219(4): 410.e1-410.e7. DOI: 10.1016/j.ajog.2018.08.033.
[27]
Ciavattini A, Clemente N, Delli Carpini G, et al. Number and size of uterine fibroids and obstetric outcomes[J]. J Matern Fetal Neonatal Med, 2015, 28(4): 484-488. DOI: 10.3109/14767058.2014.921675.
[28]
Karlsen K, Schiøler Kesmodel U, Mogensen O, et al. Relationship between a uterine fibroid diagnosis and the risk of adverse obstetrical outcomes: a cohort study[J]. BMJ Open, 2020, 10(2): e032104. DOI: 10.1136/bmjopen-2019-032104.
[29]
Zhao R, Wang X, Zou L, et al. Adverse obstetric outcomes in pregnant women with uterine fibroids in China: a multicenter survey involving 112, 403 deliveries[J]. PLoS One, 2017, 12(11): e0187821. DOI: 10.1371/journal.pone.0187821.
[30]
Coutinho LM, Assis WA, Spagnuolo-Souza A, et al. Uterine fibroids and pregnancy: how do they affect each other?[J]. Reprod Sci, 2022, 29(8): 2145-2151. DOI: 10.1007/s43032-021-00656-6.
[31]
Jenabi E, Fereidooni B. The uterine leiomyoma and placenta previa: a Meta-analysis[J]. J Matern Fetal Neonatal Med, 2019, 32(7): 1200-1204. DOI: 10.1080/14767058.2017.1400003.
[32]
王阳,赵岩. 初次妊娠患者发生前置胎盘的影响因素分析[J]. 中国医科大学学报2021, 50(5): 449-452. DOI: 10.12007/j.issn.0258-4646.2021.05.013.
[33]
Jenabi E, Ebrahimzadeh Zagami S. The association between uterine leiomyoma and placenta abruption: a Meta-analysis[J]. J Matern Fetal Neonatal Med, 2017, 30(22): 2742-2746. DOI: 10.1080/14767058.2016.1261401.
[34]
Harada T, Taniguchi F, Harada T. Increased risk of obstetric complications in patients with adenomyosis: a narrative literature review[J]. Reprod Med Biol, 2022, 21(1): e12473. DOI: 10.1002/rmb2.12473.
[35]
Jenabi E, Khazaei S. The effect of uterine leiomyoma on the risk of malpresentation and cesarean: a Meta-analysis[J]. J Matern Fetal Neonatal Med, 2018, 31(1): 87-92. DOI: 10.1080/14767058.2016.1275553.
[36]
王红梅,沈汝冈,杨惠娟,等. 双胎妊娠合并肌壁间子宫肌瘤孕妇剖宫产术时行肌瘤剔除术的安全性分析[J]. 中华妇产科杂志2022, 57(11): 843-849. DOI: 10.3760/cma.j.cn112141-20220721-00472.
[37]
路畅,胡江涛,李金皎,等. 剖宫产分娩中不同类型子宫肌瘤剔除术的临床特征分析[J]. 首都医科大学学报2022, 43(4): 653-657. DOI: 10.3969/j.issn.1006-7795.2022.04.022.
[38]
Lam SJ, Best S, Kumar S. The impact of fibroid characteristics on pregnancy outcome[J]. Am J Obstet Gynecol, 2014, 211(4): 395.e1-395.e5. DOI: 10.1016/j.ajog.2014.03.066.
[39]
路畅,胡江涛,王晓丹,等. 妊娠合并子宫肌瘤产科特征及妊娠结局临床分析[J]. 中国临床医生杂志2022, 50(10): 1221-1225. DOI: 10.3969/j.issn.2095-8552.2020.10.026.
[40]
Mitro SD, Sundaram R, Chen Z, et al. Leiomyomata, neonatal anthropometry, and pregnancy outcomes in singleton pregnancies[J]. Ann Epidemiol, 2023, 80: 43-52. DOI: 10.1016/j.annepidem.2023.02.008.
[41]
张红媛,顾永忠. 妊娠早期巨大子宫肌瘤术后分娩1例并文献复习[J]. 山东大学学报(医学版), 2023, 61(1): 69-73. DOI: 10.6040/j.issn.1671-7554.0.2022.0981.
[1] 杨皓媛, 龚杰, 邹青伟, 阮航. 哮喘孕妇的母婴不良妊娠结局研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 522-529.
[2] 陈甜甜, 王晓东, 余海燕. 双胎妊娠合并Gitelman综合征孕妇的妊娠结局及文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 559-568.
[3] 居晓庆, 金蕴洁, 王晓燕. 剖宫产术后瘢痕子宫患者再次妊娠阴道分娩发生子宫破裂的影响因素分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 575-581.
[4] 顾娟, 孙擎擎, 胡方方, 曹义娟, 祁玉娟. 子宫内膜容受性检测改善胚胎反复种植失败患者妊娠结局的临床应用[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 582-587.
[5] 王蓓蓓, 董启秀, 郗红燕, 于庆云, 张丽君, 式光. 早孕期孕妇药物流产失败的影响因素分析与构建相关预测模型及其对药物流产成功的预测价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 588-594.
[6] 陈絮, 詹玉茹, 王纯华. 孕妇ABO血型联合甲状腺功能检测对预测妊娠期糖尿病的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 604-610.
[7] 胡诤贇, 史建伟, 申建伟, 王冰, 蒋春苗, 刘冲. 基于机器学习鉴定早产儿支气管肺发育不良的关键基因[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 446-454.
[8] 冉晨曦, 沈如飞, 廖明钰, 廖倩, 周玲, 张玉玲, 隆敏. 垂体瘤孕妇的诊治与围分娩期管理[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 487-491.
[9] 胡金科, 钟文. 妊娠期输尿管结石的处理与转归[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 377-381.
[10] 王跃, 唐敏, 李鹏超, 吕强. 妊娠期膀胱副神经节瘤伴严重出血一例报告[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 410-411.
[11] 杨聚荣. 透析患者妊娠的管理[J]. 中华肾病研究电子杂志, 2023, 12(05): 300-300.
[12] 张郁妍, 胡滨, 张伟红, 徐楣, 朱慧, 羊馨玥, 刘海玲. 妊娠中期心血管超声参数与肝功能的相关性及对不良妊娠结局的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 499-504.
[13] 王欣, 刘琳, 闻哲嘉, 刘春玲, 张弘, 吕芳. 妊娠前应激暴露对小鼠后续妊娠的影响[J]. 中华临床医师杂志(电子版), 2023, 17(04): 431-437.
[14] 刘雪云, 范颖, 姚爱军, 张胜苗, 吕亚妮, 张冰清, 张晓宇, 刘恒. 基于微信小程序的个体化、全程护理干预对孕妇孕期体重及分娩结局的影响[J]. 中华临床医师杂志(电子版), 2023, 17(04): 455-460.
[15] 邹艳丽, 栾文杰, 王淑娟, 刘亚琴, 初桂芝, 李松洋, 王好玲, 张锦婷, 姜鑫, 栾泽东. 早孕期胎儿右位主动脉弓的产前超声诊断学特征[J]. 中华诊断学电子杂志, 2023, 11(04): 227-232.
阅读次数
全文


摘要